Fig. 5From: Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)The stages of chronic kidney disease [calculated, Cockroft Gault] at baseline by dose groupsBack to article page